As patients see multiple physicians for different conditions the potential for deadly polypharmacy interactions increases. A clinical Pain Management pharmacist discusses non-opioid medication recommendations for treating the three primary types of pain.Read More
New therapies that harness the immune system to treat cancer are causing autoimmune inflammatory conditions in patients.
Because DRG neurons are capable of modulating all sensations before processing to the central nervous system, DRG stimulation is proving to be a particularly effective therapeutic approach for chronic intractable pain.
Your patient has hemodynamically severe but asymptomatic aortic stenosis. Should you advise watchful waiting or aortic valve replacement? Some novel assessment variables might help guide the decision.
Genomic testing is increasingly impacting prostate cancer diagnosis and treatment, helping clinicians make more informed management decisions based on the specific molecular characteristics of an individual patient’s cancer. In a video interview, Eric A. Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute, discusses the broadening use of molecular-based tests.
For a young Canadian with anterior leaflet mitral valve prolapse, the opportunity to undergo robotically assisted valve repair close to his family in the Middle East just couldn’t be beat.
Find out about Dr. Carol Burke’s plans for her term as president of ACG, her thoughts on the challenges women in gastroenterology face, her role models and more in this candid Q&A.
Comparative imaging studies are demonstrating superiority of 7T over 3T MRI in enhancing lesion conspicuity in patients with a range of neurological conditions. The likely bottom line: better diagnosis in many cases.
A new study finds that chronically immunosuppressed patients with squamous cell skin cancer have dramatically higher rates of recurrence and lower rates of disease-free survival than immunocompetent patients. Intensified treatment may be merited for immunosuppressed patients
Cleveland Clinic researchers have developed a prognostic index to aid in identifying patients most likely to benefit from the tumor control and durable palliation of spine radiosurgery. The researchers found significant variability in survival after SRS and identified several key factors that are predictive of better overall survival.
For patients with head and neck cancer, a new study shows that the safety of modern IMRT re-irradiation appears significantly improved compared with previous re-irradiation results, with prolonged survival in carefully selected patients. The results may alter the common clinical perception that the risks of re-irradiation outweigh its value, and should help guide therapeutic decision-making.